Clinical value of multimodal MRI assessment of the response to apatinib mesylate thera-py in patients with advanced cervical cancer

Luxing PENG; Heming LU; Jiaxin CHEN; Hailan JIANG; Zhiping LU; Zhaohong CHEN; Shan DENG; Junzhao GU; Qiang PANG; Youjun WU; Ping LIANG

doi:10.12122/j.issn.1674-4500.2023.03.19

Luxing PENG, Heming LU, Jiaxin CHEN, Hailan JIANG, Zhiping LU, Zhaohong CHEN, Shan DENG, Junzhao GU, Qiang PANG, Youjun WU, Ping LIANG

PDF(1306 KB)

中国科技核心期刊（中国科技论文统计源期刊）
《中国学术期刊（光盘版）》收录期刊
《中国核心期刊（遴选）数据库》收录期刊
中国学术期刊综合评价数据库（CAJCED）统计源期刊
美国《乌利希期刊指南》（Ulrichsweb）来源期刊

Journal of Molecular Imaging ›› 2023, Vol. 46 ›› Issue (3) : 494-499. DOI: 10.12122/j.issn.1674-4500.2023.03.19

Clinical value of multimodal MRI assessment of the response to apatinib mesylate thera-py in patients with advanced cervical cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 46(3): 494-499 https://doi.org/10.12122/j.issn.1674-4500.2023.03.19

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1306 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-01-12	2023-05-20
Issue Date
2024-12-20

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS